ElastiMed

Wearable Device for Improving Leg Circulation

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in June 2015 by Omer Zelka, ElastiMed operates with 1–10 employees. The company has raised a total of $4.2 million across 6 funding rounds from 6 investors.

Business overview

ElastiMed develops a wearable medical device designed to enhance blood circulation in the legs, targeting venous and lymphatic diseases. Utilizing proprietary smart materials, the battery-operated device provides continuous leg massage to address swelling and ulcers, and prevent blood clots. The device is also applicable for athletes seeking faster recovery and integrates IoT sensors for data generation and compliance monitoring. ElastiMed operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving patients, healthcare providers, and consumers in North America and Europe.

Strategic signal

In October 2024, ElastiMed announced the appointment of Dr. Amir Belson to its Board of Directors. This strategic addition signals the company's commitment to strengthening its leadership and medical expertise, which is crucial for advancing its wearable medical device technology and expanding its market presence in the competitive health tech landscape.

Company Intelligence Q&A

When was ElastiMed founded and by whom?
ElastiMed was founded in June 2015 by Omer Zelka.
Has ElastiMed made any recent board appointments?
In October 2024, ElastiMed welcomed Dr. Amir Belson as a member of its Board of Directors.
When did ElastiMed appoint Dr. Steve Elias to its Medical Advisory Board?
In January 2025, ElastiMed appointed Dr. Steve Elias to its Medical Advisory Board.